ReviewCurrent rheumatology reports2015
Update on juvenile systemic sclerosis.
Review in Current rheumatology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Clinical characteristics of juvenile systemic sclerosis in Korea: 31-year single-center study.Journal of rheumatic diseases · 2024Article
- The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis.Archives of rheumatology · 2023Article
- French recommendations for the management of systemic sclerosis.Orphanet journal of rare diseases · 2021Article
- Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study.Rheumatology international · 2021Article
- Clinical and laboratory profile of juvenile-onset systemic sclerosis in a Brazilian cohort.Journal of scleroderma and related disorders · 2019Article
- Juvenile Scleroderma: A Referral Center Experience.Archives of rheumatology · 2018Article
- New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction.Pediatric cardiology · 2017Article
- The frequency of pulmonary hypertension in patients with juvenile scleroderma.Bosnian journal of basic medical sciences · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Juvenile systemic sclerosis is an orphan disease of the macro- and microvasculature with an unknown etiology. Although pediatric and adult classification systems have been developed, neither has been validated yet. Recent publications have shown a shift in the subset pattern in juvenile-onset adult patients, with a better outcome in these patients as compared with young adult patients. As a first step in assessing activity, damage, and severity, a pediatric severity score--a modification of the adult Medsger scale--was proposed but has not been validated. An activity score also has been developed but has not yet been published. Currently, treatment approaches are based only on adult data, and problems exist in extrapolating these data to a pediatric population.
Indexed as
Identifiers
25761925What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.